Peer-reviewed articles

  1. Malinski T, Dobrucki LW, Brovkovych V. The role of nitric oxide in ischemia of the brain and heart. Shock. 1999;12: 40.
  2. Frenzel T, Krüll A, Schmidt R, Dobrucki W, Malys B, Box W. Ein Computerlernprogramm für die Strahlentherapie. Z Med Phys. 1999;9: 56–59.
  3. Brovkovych V, Dobrucki LW, Brovkovych S, Dobrucki I, Do Nascimento CA, Burewicz A, et al. Nitric oxide release from normal and dysfunctional endothelium. J Physiol Pharmacol. 1999;50: 575–586.
  4. Kidd GA, Dobrucki LW, Brovkovych V, Bohr DF, Malinski T. Nitric oxide deficiency contributes to large cerebral infarct size. Hypertension. 2000;35: 1111–1118.
  5. Dobrucki LW, Kalinowski L, Uracz W, Malinski T. The protective role of nitric oxide in the brain ischemia. J Physiol Pharmacol. 2000;51: 695–703.
  6. Brovkovych V, Dobrucki LW, Brovkovych S, Dobrucki I, Kalinowski L, Kiechle F, et al. Nitric oxide measurements during endotoxemia. Clin Chem. 2001;47: 1068–1074.
  7. Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T. Statin-stimulated nitric oxide release from endothelium. Med Sci Monit. 2001;7: 622–627.
  8. Kalinowski L, Dobrucki LW, Malinski T. Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J Endocrinol. 2001;170: 433–440.
  9. Dobrucki LW, Cabrera CL, Bohr DF, Malinski T. Central hypotensive action of clonidine requires nitric oxide. Circulation. 2001;104: 1884–1886.
  10. Kalinowski L, Dobrucki LW, Brovkovych V, Malinski T. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation. 2002;105: 933–938.
  11. Wiemer G, Dobrucki LW, Louka FR, Malinski T, Heitsch H. AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium. 2002;40: 847–852.
  12. Kalinowski L, Dobrucki LW, Szczepanska-Konkel M, Jankowski M, Martyniec L, Angielski S, et al. Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation. 2003;107: 2747–2752.
  13. Linz W, Itter G, Dobrucki LW, Malinski T, Wiemer G. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction. J Renin Angiotensin Aldosterone Syst. 2003;4: 180–185.
  14. Nanobashvili J, Neumayer C, Fuegl A, Punz A, Blumer R, Mittlböck M, Dobrucki LW, et al. Combined L-arginine and antioxidative vitamin treatment mollifies ischemia-reperfusion injury of skeletal muscle. J Vasc Surg. 2004;39: 868–877.
  15. Dobrucki LW, Sinusas AJ. Cardiovascular molecular imaging. Semin Nucl Med. 2005;35: 73–81.
  16. Dobrucki LW, Sinusas AJ. Molecular imaging – A new approach to nuclear cardiology. Q J Nucl Med Mol Imaging. 2005;49: 106–115.
  17. Hua J, Dobrucki LW, Sadeghi MM, Zhang J, Bourke BN, Cavaliere P, et al. Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation. 2005;111: 3255–3260.
  18. Li S, Dobrucki LW, Sinusas AJ, Liu Y-H. A new method for SPECT quantification of targeted radiotracers uptake in the myocardium. Med Image Comput Comput Assist Interv. 2005;8: 684–691.
  19. Jackowski M, Papademetris X, Dobrucki LW, Sinusas AJ, Staib LH. Characterizing vascular connectivity from microCT images. Med Image Comput Comput Assist Interv. 2005;8: 701–708.
  20. Dobrucki LW, Sinusas AJ. Molecular cardiovascular imaging. Curr Cardiol Rep. 2005;7: 130–135.
  21. Dobrucki LW, Sinusas AJ. Molecular imaging. A new approach to nuclear cardiology. Q J Nucl Med Mol Imaging. 2005;49: 106–115.
  22. Su H, Spinale FG, Dobrucki LW, Song J, Hua J, Sweterlitsch S, et al. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation. 2005;112: 3157–3167.
  23. Lindsey ML, Escobar GP, Dobrucki LW, Goshorn DK, Bouges S, Mingoia JT, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006;290: H232-9.
  24. Goyal A, Wang Y, Su H, Dobrucki LW, Brennan M, Fong P, et al. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. J Pediatr Surg. 2006;41: 787–791.
  25. Luo D, Luo Y, He Y, Zhang H, Zhang R, Li X, Dobrucki LW, et al. Differential Functions of Tumor Necrosis Factor Receptor 1 and 2 Signaling in Ischemia-Mediated Arteriogenesis and Angiogenesis. Am J Pathol. 2006;169: 1886–1898.
  26. Dobrucki LW, Sinusas AJ. Imaging angiogenesis. Curr Opin Biotechnol. 2007;18: 90–96.
  27. Kalinowski L, Dobrucki LW, Meoli DF, Dione DP, Sadeghi MM, Madri JA, et al. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. J Appl Physiol. 2008;104: 1504–1512.
  28. Zhang J, Nie L, Razavian M, Ahmed M, Dobrucki LW, Asadi A, et al. Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling. Circulation. 2008;118: 1953–1960.
  29. Dobrucki LW, Dione DP, Kalinowski L, Dione D, Mendizabal M, Yu J, et al. Serial noninvasive targeted imaging of peripheral angiogenesis: validation and application of a semiautomated quantitative approach. J Nucl Med. 2009;50: 1356–1363.
  30. Suh JW, Scheinost D, Dione DP, Dobrucki LW, Sinusas AJ, Papademetris X. A non-rigid registration method for serial microCT mouse hindlimb images. Med Image Comput Comput Assist Interv. 2009;12: 688–695.
  31. Qian X, Brennan MP, Dione DP, Dobrucki WL, Jackowski MP, Breuer CK, et al. A non-parametric vessel detection method for complex vascular structures. Med Image Anal. 2009;13: 49–61.
  32. Dobrucki LW, Meoli DF, Hu J, Sadeghi MM, Sinusas AJ. Regional hypoxia correlates with the uptake of a radiolabeled targeted marker of angiogenesis in rat model of myocardial hypertrophy and ischemic injury. J Physiol Pharmacol. 2009;60 Suppl 4: 117–123.
  33. Dobrucki LW, Marsh BJ, Kalinowski L. Elucidating structure-function relationships from molecule-to-cell-to-tissue: from research modalities to clinical realities. J Physiol Pharmacol. 2009;60 Suppl 4: 83–93.
  34. Dobrucki LW, de Muinck ED, Lindner JR, Sinusas AJ. Approaches to Multimodality Imaging of Angiogenesis. J Nucl Med. 2010. doi:jnumed.110.074963 [pii] 10.2967/jnumed.110.074963
  35. Dobrucki LW, Tsutsumi Y, Kalinowski L, Dean J, Gavin M, Sen S, et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J Mol Cell Cardiol. 2010;48: 1071–1079.
  36. Dobrucki LW, Sinusas AJ. PET and SPECT in cardiovascular molecular imaging. Nat Rev Cardiol. 2010;7: 38–47.
  37. Razavian M, Zhang J, Nie L, Tavakoli S, Razavian N, Dobrucki LW, et al. Molecular Imaging of Matrix Metalloproteinase Activation to Predict Murine Aneurysm Expansion In Vivo. J Nucl Med. 2010;51: 1107–1115.
  38. Spinale FG, Mukherjee R, Zavadzkas JA, Koval CN, Bouges S, Stroud RE, Dobrucki LW, et al. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction. J Biol Chem. 2010;285: 30316–30327.
  39. Tavakoli S, Razavian M, Zhang J, Nie L, Marfatia R, Dobrucki LW, et al. Matrix metalloproteinase activation predicts amelioration of remodeling after dietary modification in injured arteries. Arterioscler Thromb Vasc Biol. 2011;31: 102–109.
  40. Suh JW, Scheinost D, Dione DP, Dobrucki LW, Sinusas AJ, Papademetris X. A non-rigid registration method for serial lower extremity hybrid SPECT/CT imaging. Med Image Anal. 2011;15: 96–111.
  41. Liu Y-H, Sahul Z, Weyman CA, Dione DP, Dobrucki WL, Mekkaoui C, et al. Accuracy and Reproducibility of Absolute Quantification of Myocardial Focal Tracer Uptake from Molecularly Targeted SPECT/CT: A Canine Validation. J Nucl Med. 2011;52: 453–460.
  42. Sahul ZH, Mukherjee R, Song J, McAteer J, Stroud RE, Dione DP, Dobrucki LW, et al. Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction. Circ Cardiovasc Imaging. 2011;4: 381–391.
  43. Hibino N, Villalona G, Pietris N, Duncan DR, Schoffner A, Roh JD, Dobrucki LW, et al. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. The FASEB Journal. 2011;25: 2731–2739.
  44. Criscione JM, Dobrucki LW, Zhuang ZW, Papademetris X, Simons M, Sinusas AJ, et al. Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging. Bioconjug Chem. 2011;22: 1784–1792.
  45. Razavian M, Tavakoli S, Zhang J, Nie L, Dobrucki LW, Sinusas AJ, et al. Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by In Vivo Molecular Imaging of Matrix Metalloproteinase Activation. J Nucl Med. 2011;52: 1795–1802.
  46. Dobrucki LW, Kalinowski L. Molecular Imaging of Left Ventricular Remodeling. Curr Cardiovasc Imaging Rep. 2012;5: 188–197.
  47. Dobrucki I, Schuelke MR, Lapi S, Dobrucki LW. Novel 64Cu-labeled targeted agent provides favorable biodistribution, high purity, and stability for PET imaging of angiogenesis. J Nucl Med. 2012;53: 28.
  48. Hedhli N, Dobrucki LW, Kalinowski A, Zhuang ZW, Wu X, Russell RR 3rd, et al. Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis. Cardiovasc Res. 2012;93: 516–524.
  49. Domagala TB, Szeffler A, Dobrucki LW, Dropinski J, Polanski S, Leszczynska-Wiloch M, et al. Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels. Hypertension. 2012;59: 825–832.
  50. Tang L, Yang X, Dobrucki LW, Chaudhury I, Yin Q, Yao C, et al. Aptamer-Functionalized, Ultra-Small, Monodisperse Silica Nanoconjugates for Targeted Dual-Modal Imaging of Lymph Nodes with Metastatic Tumors. Angewandte Chemie – International Edition. 2012;51: 12721–12726.
  51. Yin Q, Tong R, Xu Y, Baek K, Dobrucki LW, Fan TM, et al. Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates. Biomacromolecules. 2013;14: 920–929.
  52. Yin Q, Yap FY, Yin L, Ma L, Zhou Q, Dobrucki LW, et al. Poly(iohexol) nanoparticles as contrast agents for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2013;135: 13620–13623.
  53. Xing H, Tang L, Yang X, Hwang K, Wang W, Yin Q, Dobrucki LW, et al. Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo. J Mater Chem B Mater Biol Med. 2013;1: 5288–5297.
  54. Li S, Sinusas AJ, Dobrucki LW, Liu Y-H. New approach to quantification of molecularly targeted radiotracer uptake from hybrid cardiac SPECT/CT: methodology and validation. J Nucl Med. 2013;54: 2175–2181.
  55. Mehra VC, Jackson E, Zhang XM, Jiang X-C, Dobrucki LW, Yu J, et al. Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis. Am J Pathol. 2014;184: 1562–1576.
  56. Tang L, Yang X, Yin Q, Cai K, Wang H, Chaudhury I, Dobrucki LW, et al. Investigating the optimal size of anticancer nanomedicine. Proc Natl Acad Sci U S A. 2014;111: 15344–15349.
  57. Hedhli J, Schuh S, Czerwinski A, Huntsman H, Dobrucka I, Slania S, Dobrucki LW, et al. Molecular imaging of stem cells induced angiogenesis at the onset of microvascular complications in type-1 diabetes. J Nucl Med. 2015;56: 590.
  58. Li J, Dobrucki LW, Marjanovic M, Chaney EJ, Suslick KS, Boppart SA. Enhancement and wavelength-shifted emission of Cerenkov luminescence using multifunctional microspheres. Phys Med Biol. 2015;60: 727–739.
  59. Tang L, Yin Q, Xu Y, Zhou Q, Cai K, Yen J, Dobrucki LW, et al. Bioorthogonal oxime ligation mediated in vivo cancer targeting. Chem Sci. 2015;6: 2182–2186.
  60. Dobrucki LW, Pan D, Smith AM. Multiscale Imaging of Nanoparticle Drug Delivery. Curr Drug Targets. 2015;16: 560–570.
  61. Mu Z, Dobrucki LW, Liu Y-H. SPECT Imaging of 2-D and 3-D Distributed Sources with Near-Field Coded Aperture Collimation: Computer Simulation and Real Data Validation. J Med Biol Eng. 2016;36: 32–43.
  62. Wang H, Tang L, Liu Y, Dobrucka IT, Dobrucki LW, Yin L, et al. In VivoTargeting of Metabolically Labeled Cancers with Ultra-Small Silica Nanoconjugates. Theranostics. 2016;6: 1467–1476.
  63. Ma L, Liu T-W, Wallig MA, Dobrucki IT, Dobrucki LW, Nelson ER, et al. Efficient Targeting of Adipose Tissue Macrophages in Obesity with Polysaccharide Nanocarriers. ACS Nano. 2016;10: 6952–6962.
  64. Yin Q, Tang L, Cai K, Tong R, Sternberg R, Yang X, Dobrucki LW, et al. Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis. Proceedings of the National Academy of Sciences. 2016;113: E4601–E4609.
  65. Wang H, Wang R, Cai K, He H, Liu Y, Yen J, Dobrucki LW, et al. Selective in vivo metabolic cell-labeling-mediated cancer targeting. Nat Chem Biol. 2017;13: 415–424.
  66. Huntsman H, Merritt J, Pincu Y, Cobert A, De Lisio M, Dvoretskiy S, Dobrucki LW, et al. Preconditioned Mesenchymal Stem Cells Improve Muscle Function and Neuroplasticity in Aged Mice. Exp Geron. 2017.
  67. Hedhli J, Konopka CJ, Schuh S, Bouvin H, Cole JA, Huntsman HD, Dobrucki LW, et al. Multimodal Assessment of Mesenchymal Stem Cell Therapy for Diabetic Vascular Complications. Theranostics. 2017;7: 3876–3888.
  68. Knox HJ, Hedhli J, Kim TW, Khalili K, Dobrucki LW, Chan J. A bioreducible N-oxide-based probe for photoacoustic imaging of hypoxia. Nat Commun. 2017;8. doi:10.1038/s41467-017-01951-0
  69. Hedhli J, Konopka CJ, Ploska A, Schuh S, Kalinowski L, Dobrucka IT, Dobrucki LW, et al. Molecular imaging of tumor microenvironment to study synergistic effects of therapy with doxorubicin and CAMs. J Nucl Med. 2017;58: 1021.
  70. Hedhli J, Czerwinski A, Schuelke M, Płoska A, Sowinski P, Hood LL, Dobrucki LW Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α V β 3 Integrin Activity. Sci Rep. 2017;7: 3185.
  71. Kim M, Abbey CK, Hedhli J, Dobrucki LW, Insana MF. Expanding Acquisition and Clutter Filter Dimensions for Improved Perfusion Sensitivity. IEEE Trans Ultrason Ferroelectr Freq Control. 2017;64: 1429–1438.
  72. Lee J, Abdeen AA, Hedhli J, Wycislo KL, Dobrucka IT, Fan TM, Dobrucki LW, et al. Melanoma topology reveals a stem-like phenotype that promotes angiogenesis. Science Advances. 2017;3: e1701350.
  73. Huntsman HD, Rendeiro C, Merritt JR, Pincu Y, Cobert A, De Lisio M, Dobrucki LW, et al. The impact of mechanically stimulated muscle-derived stromal cells on aged skeletal muscle. Exp Gerontol. 2018;103: 35–46.
  74. Janaszak-Jasiecka A, Siekierzycka A, Bartoszewska S, Serocki M, Dobrucki LW, Collawn JF, et al. eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells. Angiogenesis. 2018. doi:10.1007/s10456-018-9620-y
  75. Ganguli A, Ornob A, Spegazzini N, Liu Y, Damhorst G, Ghonge T, Dobrucki LW, et al. Pixelated spatial gene expression analysis from tissue. Nat Commun. 2018;9. doi:10.1038/s41467-017-02623-9
  76. Yin Q, Tang L, Cai K, Yang X, Yin L, Zhang Y, Dobrucki LW, et al. Albumin as a “Trojan Horse” for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting. Biomaterials Science. 2018;6: 1189–1200.
  77. Konopka CJ, Wozniak M, Hedhli J, Ploska A, Schwartz-Duval A, Siekierzycka A, Dobrucki Multimodal Imaging of the Receptor for Advanced Glycation End-Products with Molecularly Targeted Nanoparticles. Theranostics. 2018;
  78. Kim M, Yang Z, Hedhli J, Dobrucki LW, Insana MF. Multi-dimensional clutter filter optimization for ultrasonic perfusion imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2018; (in review).
  79. Hedhli J, Kim M, Knox HJ, Huynh T, Schuelke M, Dobrucki IT, Dobrucki LW, et al. A Non-Invasive Lens into Vascular Repair in a Model of Peripheral Arterial Disease. Circulation. 2018.
  80. Anorma C, Hedhli J, Bearrood TE, Pino NW, Gardner SH, Inaba H, Dobrucki LW, et al. Surveillance of Cancer Stem Cell Plasticity Using an Isoform-Selective Fluorescent Probe for Aldehyde Dehydrogenase 1A1. ACS Central Science. 2018;4: 1045–1055.
  81. Kim M, Zhu Y, Hedhli J, Dobrucki LW, Insana MF. Multidimensional Clutter Filter Optimization for Ultrasonic Perfusion Imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2018;65: 2020–2029.
  82. Hedhli J, Slania SLL, Płoska A, Czerwinski A, Konopka CJ, Wozniak M, Dobrucki LW, et al. Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice. Sci Rep. 2018;8: 5401.
  83. Schwartz-Duval A, Konopka CJ, Daza E, Srivastava I, Johnson E, Kampert T, Dobrucki LW, et al. An ‘Omics’ Approach Towards a Cell-level Personalization of Nanomedicine: In vitro Reduction of Gold Nanoparticles by Action of Mammalian Cells. Nat Nanotechnol. 2019.
  84. Hedhli J, Kim M, Knox HJ, Cole JA, Huynh T, Schuelke M, Dobrucki LW, et al. Imaging the Landmarks of Vascular Recovery. 2020;10: 1733–1745.
  85. Samotij D, Nedoszytko B, Bartosińska J, Batycka-Baran A, Czajkowski R, Dobrucki I, Dobrucki LW, et al. Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances. Advances in Dermatology and Allergology. 2020;37: 135–153.
  86. Szczerkowska-Dobosz A, Krasowska D, Bartosińska J, Stawczyk-Macieja M, Walczak A, Owczarczyk-Saczonek A, Dobrucki LW, et al. Pathogenesis of psoriasis in the “omic” era. Part IV. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis. Advances in Dermatology and Allergology. 2020;37: 625–634.
  87. Owczarczyk-Saczonek A, Purzycka-Bohdan D, Nedoszytko B, Reich A, Szczerkowska-Dobosz A, Bartosińska J, Dobrucki LW, et al. Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis in psoriasis. Advances in Dermatology and Allergology. 2020;37: 452–467.
  88. Nedoszytko B, Szczerkowska-Dobosz A, Stawczyk-Macieja M, Owczarczyk-Saczonek A, Reich A, Bartosińska J, Dobrucki LW, et al. Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis. Advances in Dermatology and Allergology. 2020;37: 283–298.
  89. Lin J, Park P, Li H, Oh MW, Dobrucki IT, Dobrucki W, et al. Streptococcus pneumoniae elaborates persistent and prolonged competent state during pneumonia-derived sepsis. Infect Immun. 2020. doi:10.1128/IAI.00919-19
  90. Deng H, Konopka CJ, Cross T-WL, Swanson KS, Dobrucki LW, Smith AM. Multimodal Nanocarrier Probes Reveal Superior Biodistribution Quantification by Isotopic Analysis over Fluorescence. ACS Nano. 2020;14: 509–523.
  91. Dobrucki LW, Sinusas AJ. Targeted Imaging of Abdominal Aortic Aneurysm. Circ Cardiovasc Imaging. 2020;13: e010495.
  92. Misra C, Bangru S, Lin F, Lam K, Koenig SN, Lubbers ER, Dobrucki LW, et al. Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy. Dev Cell. 2020;52: 748-763.e6.
  93. Konopka CJ, Woźniak M, Hedhli J, Siekierzycka A, Skokowski J, Pęksa R, Dobrucki Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer. Eur J Nucl Med Mol Imaging. 2020
  94. Gorska-Ponikowska M, Ploska A, Jacewicz D, Szkatula M, Barone G, Lo Bosco G, Dobrucki LW, et al. Modification of DNA structure by reactive nitrogen species as a result of 2-methoxyestradiol–induced neuronal nitric oxide synthase uncoupling in metastatic osteosarcoma cells. Redox Biology. 2020;32: 101522.
  95. Schwartz-Duval AS, Konopka CJ, Moitra P, Daza EA, Srivastava I, Johnson EV, Dobrucki LW, et al. Intratumoral generation of photothermal gold nanoparticles through a vectorized biomineralization of ionic gold. Nat Commun. 2020;11: 4530.
  96. Prabhu S, Deng H, Cross T-WL, Shahoei SH, Konopka CJ, Gonzalez Medina N, Dobrucki LW, et al. Nanocarriers targeting adipose macrophages increase glucocorticoid anti-inflammatory potency to ameliorate metabolic dysfunction. Biomaterials Science. 2021;9: 506–518.
  97. Blair S, Garcia M, Davis T, Zhu Z, Liang Z, Konopka C, Dobrucki LW, et al. Hexachromatic bioinspired camera for image-guided cancer surgery. Sci Transl Med. 2021;13: eaaw7067.
  98. Woźniak M, Konopka CJ, Płoska A, Hedhli J, Siekierzycka A, Banach M, Dobrucki LW, et al. Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease. Cell Mol Biol Lett. 2021;26: 10.
  99. Deng H, Konopka CJ, Prabhu S, Sarkar S, Medina NG, Fayyaz M, Dobrucki LW, et al. Dextran-mimetic quantum dots for multimodal macrophage imaging in vivo, ex vivo, and in situ. ACS Nano. 2022;16: 1999–2012.
  100. Woźniak M, Płoska A, Siekierzycka A, Dobrucki LW, Kalinowski L, Dobrucki IT. Molecular imaging and nanotechnology-emerging tools in diagnostics and therapy. Int J Mol Sci. 2022;23: 2658.
  101. Applegate CC, Deng H, Kleszynski BL, Cross T-WL, Konopka CJ, Dobrucki LW, et al. Impact of administration route on nanocarrier biodistribution in a murine colitis model. J Exp Nanosci. 2022;17: 599–616.
  102. Janaszak-Jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets. Cell Mol Biol Lett. 2023;28: 21.
  103. Babaei S, Dai B, Abbey CK, Ambreen Y, Dobrucki WL, Insana MF. Monitoring muscle perfusion in rodents during short-term ischemia using power Doppler ultrasound. Ultrasound Med Biol. 2023;49: 1465–1475.
  104. Yu Z, Moshood Y, Wozniak MK, Patel S, Terpstra K, Llano DA, Dobrucki LW, et al. Amphiphilic molecules exhibiting zwitterionic excited-state intramolecular proton transfer and near-infrared emission for the detection of amyloid β aggregates in Alzheimer’s disease. Chemistry. 2023; e202302408.
  105. Applegate CC, Nelappana MB, Nielsen EA, Kalinowski L, Dobrucki IT, Dobrucki RAGE as a novel biomarker for prostate cancer: a systematic review and meta-analysis. Cancers (Basel). 2023 Oct 9;15(19):4889. doi: 10.3390/cancers15194889.
  106. Yu Z, Blade G, Bouley BS, Dobrucki IT, Dobrucki LW, Mirica LM. Coordination chemistry of sulfur-containing bifunctional chelators: Toward in vivo stabilization of 64cu PET imaging agents for Alzheimer’s disease. Inorg Chem. 2023;62: 20820–20833.
  107. Płoska A, Wozniak M, Hedhli J, Konopka CJ, Skondras A, Matatov S, Dobrucki LW, et al. In vitro and in vivo imaging-based evaluation of doxorubicin anticancer treatment in combination with the herbal medicine black cohosh. Int J Mol Sci. 2023;24: 17506.